SCHEMBL20090136

SCHEMBL20090136

O=P(c1ccccc1)(c1ccccc1)c1ccc2cc(-c3cccc4nc5c6c7ccccc7ccc6c6cc7ccccc7cc6n5c34)ccc2c1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20090137 0.95 FLT3 (0.33) FLT3KDM4EALDH1A1
SCHEMBL20090139 0.94 FLT3 (0.32) FLT3
SCHEMBL20090223 0.86 HPGD (0.34) FLT3KDM4EALDH1A1
SCHEMBL19960198 0.86 ALDH1A1 (0.38) FLT3KDM4EALDH1A1
SCHEMBL19960096 0.84 KDM4E (0.36) KDM4EALDH1A1
SCHEMBL19960095 0.84 KDM4E (0.36) KDM4EALDH1A1
SCHEMBL20090135 0.84
SCHEMBL19960092 0.83 CAMKK1 (0.32)
SCHEMBL19960093 0.83 AHR (0.34) KDM4E
SCHEMBL20090224 0.83 HPGD (0.34) FLT3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 FLT3 1211/4885KDM4E 1997/4885ALDH1A1 750/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 FLT3 1211/4885KDM4E 1997/4885ALDH1A1 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.